Compare WDS & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WDS | WAT |
|---|---|---|
| Founded | 1954 | 1958 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Laboratory Analytical Instruments |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.8B | 29.3B |
| IPO Year | N/A | 1996 |
| Metric | WDS | WAT |
|---|---|---|
| Price | $23.59 | $326.40 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $379.19 |
| AVG Volume (30 Days) | ★ 1.6M | 870.2K |
| Earning Date | 02-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.57% | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | N/A | ★ 10.76 |
| Revenue | N/A | ★ $3,165,286,000.00 |
| Revenue This Year | $2.53 | $104.66 |
| Revenue Next Year | $5.73 | $10.42 |
| P/E Ratio | ★ $11.81 | $30.84 |
| Revenue Growth | N/A | ★ 6.99 |
| 52 Week Low | $12.48 | $275.05 |
| 52 Week High | $25.19 | $414.15 |
| Indicator | WDS | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 54.67 | 62.02 |
| Support Level | $22.44 | $323.46 |
| Resistance Level | $24.98 | $335.65 |
| Average True Range (ATR) | 0.59 | 8.73 |
| MACD | -0.23 | 4.61 |
| Stochastic Oscillator | 47.52 | 83.95 |
Incorporated in 1954 and named after the small Victorian town of Woodside, Woodside's early exploration focus moved from Victoria's Gippsland Basin to Western Australia's Carnarvon Basin. First LNG production from the North West Shelf came in 1984. BHP Billiton and Shell each had 40% shareholdings before BHP sold out in 1994 and Shell sold down to 34%. In 2017 Shell sold its entire shareholding. Woodside is one of the most LNG-leveraged companies globally.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.